Viewing Study NCT04446351

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-01-25 @ 1:01 PM
Study NCT ID: NCT04446351
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-27
First Post: 2020-06-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GSK6097608 View
None dostarlimab View
None Dose escalation View
None Pharmacokinetics View
None Pharmacodynamics View
None Advanced solid tumors View
None First-time-in-human View
None GSK4428859A View
None EOS884448 View
None cobolimab View
None belrestotug View